A share price of Verastem Inc [VSTM] is currently trading at $7.2, up 1.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VSTM shares have gain 4.65% over the last week, with a monthly amount drifted -23.65%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Jefferies started tracking the stock with Buy rating on April 10, 2025, and set its price target to $15. On March 24, 2025, H.C. Wainwright reiterated its Buy rating and revised its price target to $10 on the stock. BTIG Research reiterated its Buy rating and increased its price target to $20 on December 31, 2024. Guggenheim initiated its recommendation with a Buy and recommended $13 as its price target on September 30, 2024. In a note dated September 27, 2023, B. Riley Securities initiated a Buy rating and provided a target price of $21 on this stock.
Verastem Inc experienced fluctuations in its stock price throughout the past year between $4.01 and $11.24. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Verastem Inc [NASDAQ: VSTM] shares were valued at $7.2 at the most recent close of the market. An investor can expect a potential return of 94.44% based on the average VSTM price forecast.
Analyzing the VSTM fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -11.98%, Pretax Profit Margin comes in at -18.01%, and Net Profit Margin reading is -18.02%. To continue investigating profitability, this company’s Return on Assets is posted at -1.36, Equity is 23.64 and Total Capital is -1.37. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-5.76.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Verastem Inc [NASDAQ:VSTM] is 2.58. Further, the Quick Ratio stands at 2.55, while the Cash Ratio is 2.31. Considering the valuation of this stock, the price to sales ratio is 40.53.
Transactions by insiders
Recent insider trading involved Calkins Daniel, Chief Financial Officer, that happened on Dec 24 ’25 when 80.0 shares were sold. Director, Stuglik Brian M completed a deal on Dec 16 ’25 to sell 592.0 shares. Meanwhile, President and CEO Paterson Dan sold 393.0 shares on Dec 16 ’25.
